Vicor (VICR) Insider Option Grant: 4,539 Shares, $44.07 Strike

Rhea-AI Filing Summary

Vicor Corporation (VICR) – Form 4 insider transaction summary

On 06/20/2025, director Andrew D’Amico received a non-qualified stock option for 4,539 common shares of Vicor. The option’s exercise price is $44.07—generally the market price at the grant date—and it will expire on 06/20/2035. According to the footnote, the grant was made under the company’s Amended and Restated 2000 Stock Option and Incentive Plan and will vest ratably over five years. No shares were purchased or sold outright; the filing only records the derivative security grant. Following the transaction, D’Amico beneficially owns 4,539 derivative securities (options) and no change to any direct common-stock position is disclosed.

This type of grant is a routine component of director compensation. It modestly aligns the director’s interests with shareholders by linking potential value to future share-price performance, but the size of the grant—4,539 shares, roughly US$0.2 million based on the strike price—is small relative to Vicor’s market capitalization and average daily trading volume. There are no cash proceeds to Vicor and no immediate dilution because the options are unexercised. Investors should consider it an ordinary governance event rather than a signal of near-term fundamental change.

Insights

Corporate Governance Specialist

TL;DR: Routine director option grant; minimal economic or dilution impact; neutral governance signal.

The Form 4 discloses a single non-qualified option grant to director Andrew D’Amico. At 4,539 shares, the award is consistent with typical director compensation levels for companies of Vicor’s size. Vesting over five years promotes long-term alignment without encouraging short-term risk-taking. Strike price mirrors market price, so no intrinsic value exists today. From a governance standpoint, the company continues to use its 2000 Stock Option & Incentive Plan, indicating established compensation practices. There is no evidence of preferential pricing, accelerated vesting, or related-party concerns. Consequently, I view the filing as neutral with negligible impact on shareholder value.

Portfolio Manager

TL;DR: Insignificant to valuation; watch only if option activity accelerates.

The 4,539-share option grant represents less than 0.01% of Vicor’s 44 million shares outstanding, so potential dilution is immaterial. Because the option is out-of-the-money until the share price exceeds $44.07, there is no earnings impact under current accounting until vesting triggers expense recognition, which should be minor. I do not alter my position sizing or valuation models based on this disclosure. However, I track cumulative option overhang; if similar grants become frequent or larger, dilution could slowly creep higher. For now, the event remains non-impactful.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

D'Amico Andrew

(Last) (First) (Middle)

25 FRONTAGE RD.

(Street)

ANDOVER MA 01810

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
VICOR CORP [ vicr ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non Qualified Stock Option	$44.07	06/20/2025		A		4,539		(1)	06/20/2035	Common Stock	4,539	$0	4,539	D

Explanation of Responses:

1. Granted under the Companys Amended and Restated 2000 Stock Option and Incentive Plan on June 20, 2025 and vest over a five year period.

	/s/Quentin A. Fendelet Attorney in fact for Andrew D'Amico	06/23/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Vicor (VICR) report in the latest Form 4?

An option grant of 4,539 shares to director Andrew D’Amico at a $44.07 exercise price, dated 06/20/2025.

How many options were granted and at what strike price?

The filing shows 4,539 non-qualified stock options with a strike price of $44.07 per share.

When do the options granted to Andrew D’Amico expire?

They expire on 06/20/2035, providing a 10-year exercise window.

What is the vesting schedule for the new VICR options?

Per the footnote, the options vest over five years under the company’s 2000 Stock Option & Incentive Plan.

Does this Form 4 indicate any share sales or purchases?

No. It only records the grant of derivative securities; no common shares were bought or sold.